Impact Factor

The Cochrane Database of Systematic Reviews (CDSR) impact factor for 2016 is 6.264. 

The 2016 impact factor for Cochrane Eyes and Vision is 4.444.

The top 10 most cited Cochrane Eyes and Vision reviews contributing to the 2016 impact factor are:

  1. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
  2. Systemic safety of bevacizumab versus ranibizumabfor neovascular age-related macular degeneration
  3. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis
  4. Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy
  5. 5-Fluorouracil for glaucoma surgery
  6. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion
  7. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy
  8. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy
  9. Laser photocoagulation for proliferative diabetic retinopathy
  10. Medical interventions for fungal keratitis